Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > We lost 1/2 our share price since launch..

<< Previous

Bullboard Posts

Next >>

Comment by MirrorWorldManon Jun 15, 2021 12:29am

147 Views

Post# 33386704

RE:RE:RE:RE:RE:RE:We lost 1/2 our share price since launch..

My mistake, I was using 2% and not .2%. We are only getting 24 cents a tube and R+F is selling it for $66 a tube? 1067 is the active ingredient and the only reason in works so well and we are getting a quarter per tube? way to go Howie, be proud of that deal..

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?